Fast-tracking the use of copper in the NHS to tackle AMR

  22 January 2021

Rory Donnelly, clinical research director of Copper Clothing, discusses the need to fast track copper for use in the NHS as an antimicrobial material in light of the rapid roll out of COVID-19 vaccines.

COVID-19 has pushed the topic of public health to the forefront of people’s minds. From the outset, the question on everyone’s lips was, “when will we get a vaccine?”. Now that has been answered, we have seen COVID-19 vaccines rolled out at record speed, requiring immense collaborative efforts across the medical sector to ensure they can be supplied to the population as quickly and as safely as possible. But other medical innovations have not enjoyed this same experience.

Further reading: Health Europe
Author(s): Rory Donnelly
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed